What is it about?

The virus SARS-CoV-2 that caused the pandemic of 2020 needs the human host to reproduce. This makes it also vulnerable. By inhibiting a human enzyme that the virus requires but that is not essential to the host, it should be possible to inhibit the virus.

Featured Image

Why is it important?

This study provides a method for direct experimental testing and possible repurposing of existing known drugs.

Perspectives

This work could be a step in the fight against the coronavirus disease.

Jun.-Prof. Dr. Andreas Dräger
Eberhard Karls Universitat Tubingen

Read the Original

This page is a summary of: FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2, Bioinformatics, December 2020, Oxford University Press (OUP),
DOI: 10.1093/bioinformatics/btaa813.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page